Microbiome Submission Guide: What to Prepare Before You Submit

This page was reviewed on May 26, 2026 against the current BMC Microbiome submission guidelines, supporting-information instructions, research-article guidance, and Editorial Manager submission route. Manusights interpretation below applies those public requirements to manuscript-level readiness signals: abstract claim strength, methods and control architecture, figure logic, data availability, reviewer suggestions, and the cover letter.

Evidence boundary: this page uses public BMC guidance and Manusights diagnostic patterns, not private Microbiome editorial correspondence or confidential reviewer files. Official guidance explains the upload rules; the practical value here is the manuscript-readiness interpretation: whether the abstract, methods, controls, figures, data availability statement, reviewer list, and cover letter make the paper look ready for Microbiome now.

Through our diagnostic work, we have found that editors specifically look for microbiome papers where the abstract, methods, figures, controls, data availability statement, and cover letter all support a biological, ecological, functional, or clinical consequence. In practice, the named failure pattern is not that a study used amplicon sequencing or a cohort design. It is that the manuscript asks Microbiome to accept a broad claim before the evidence chain is controlled, mechanistic, and review-ready.

Microbiome is broad in organism and setting, but selective in evidence logic. Editors are usually asking:

• is this more than a descriptive community-shift paper
• does the manuscript provide real mechanistic, functional, ecological, or clinically meaningful insight
• are the controls strong enough for a microbiome claim
• is the data package ready for review right now

That is why many routine association papers misfire here. The problem is not that the topic is out of scope. It is that the paper does not yet do enough scientific work.

Microbiome's current submission guidance is unusually explicit about front-end readiness.

The practical implication is simple: flexible format lowers admin friction and raises the visibility of scientific weaknesses.

That is why authors who treat Microbiome like a convenient format-free venue often misread the journal. The flexibility is there so editors can judge the science directly. If the package still needs one more functional experiment, one more validation set, or one more round of data organization, that weakness is easier to see, not harder.

1. The manuscript is mainly descriptive

Routine 16S community-shift papers, correlation-only human cohort studies, and taxonomic surveys without functional follow-up often look too early for this journal.

2. The controls are not convincing enough

Microbiome's guidance and editorial posture make clear that contamination controls, extraction controls, amplification controls, and other design safeguards matter. Weak controls weaken trust fast.

3. The data package is not ready

If the authors still need time to organize access to the supporting datasets, the paper is not yet aligned with the journal's stated submission rules.

Before submission, a Microbiome fit and readiness check can tell you whether the problem is causality, controls, or data-release readiness.

In our pre-submission review work with microbiome manuscripts targeting Microbiome, the strongest failures are visible before upload in the abstract, methods, figures, controls, data availability statement, reviewer list, and cover letter. BMC's public guidance reduces formatting friction at initial submission, but it does not reduce the evidentiary standard. The manuscript still has to show why the microbiome result matters beyond a community description, why the control architecture can support the claim, and why the data package is ready for reviewer access now.

Failure pattern: Descriptive community shift without functional microbiome consequence

In our pre-submission review work with gut, environmental, plant, host-microbe, and clinical manuscripts targeting Microbiome, this pattern appears when the abstract makes the paper sound field-changing but the figures mainly show taxonomic shifts. The manuscript may have a clean cohort, a plausible disease or environmental context, and attractive alpha-diversity, beta-diversity, differential-abundance, or network plots. The problem is that Microbiome is not usually the strongest venue for a paper whose conclusion stops at "the community differs." The title, abstract, introduction, and final figure need to show what changed biologically, functionally, ecologically, or clinically.

The fix belongs in the manuscript components, not just in the cover letter. The abstract should state the consequence without overstating causality. The methods should explain whether the evidence comes from 16S, shotgun metagenomics, metatranscriptomics, metabolomics, culture follow-up, gnotobiotic work, longitudinal sampling, intervention data, or a defensible computational inference. Figures should connect community composition to functional pathways, host response, ecosystem process, phenotype, treatment response, or mechanistic validation. References should position the result against recent Microbiome papers and nearby venues such as The ISME Journal, Cell Host & Microbe, mSystems, Gut Microbes, Environmental Microbiome, or ISME Communications. If the strongest manuscript component is still the taxonomy figure, the paper may need another layer of functional evidence or a narrower venue.

Check whether your Microbiome manuscript has functional consequence beyond community shift →

Failure pattern: Control architecture cannot support the causal language

In our pre-submission review work with manuscripts targeting Microbiome, this failure appears when the story is interesting but the methods and controls do not protect the claim. Microbiome studies are vulnerable to contamination, batch effects, compositional artifacts, sequencing-depth artifacts, extraction-kit effects, host or environmental confounding, and overinterpretation of correlation. A manuscript can have a persuasive biological premise and still look early if the controls are buried in supplementary files, not tied to the main figures, or not strong enough for the causal verbs used in the abstract and discussion.

The practical check is component by component. The methods should name extraction controls, negative controls, positive controls, mock communities, randomized processing, batch handling, inclusion criteria, exclusion criteria, statistical analysis, and sensitivity checks where relevant. The main figures should show that the signal survives the obvious alternative explanations, not just that it reaches statistical significance. Supplementary tables should make sample exclusions and metadata completeness auditable. The cover letter should avoid claiming mechanism if the paper only shows association. References should include method and contamination-control literature, not only biological background. If reviewers would ask whether the signal is technical, compositional, or confounded, Microbiome editors can see that weakness before peer review. Sometimes the right move is to add a validation cohort, functional assay, longitudinal analysis, or mechanistic experiment before choosing between Microbiome, The ISME Journal, Cell Host & Microbe, mSystems, or a disease-specific microbiome venue.

Check whether your Microbiome controls support the manuscript's causal language →

Failure pattern: Data package is not ready at submission

In our pre-submission review work with manuscripts targeting Microbiome, this is the operational failure that authors underestimate because the journal is flexible on first-submission format. BMC's guidance says data supporting the research must be available at submission. A paper can be scientifically promising and still look unready if raw reads, processed feature tables, metadata, code, supplementary methods, and data-availability statements are incomplete. The data package is not an after-acceptance cleanup item for this journal.

The readiness check should start before the manuscript PDF is final. The data availability statement should point reviewers to accession numbers or stable repositories where appropriate, such as SRA, ENA, DDBJ, Qiita, MG-RAST, MetaboLights, Metabolomics Workbench, GitHub, Zenodo, or institutional repositories. The methods should explain preprocessing, quality control, taxonomic classification, functional annotation, statistical analysis, and reproducibility choices clearly enough for a reviewer to inspect the pipeline. Supplementary files should include sample metadata, primer or library details, software versions, and analysis outputs needed to understand the figures. The cover letter should explain any access limitations, ethics constraints, human-subjects privacy limits, or embargoes instead of hiding them. Reviewer suggestions should be credible field fits with institutional identifiers. If these components are still being assembled, Microbiome is likely to view the package as premature even if the narrative is strong.

Check whether your Microbiome data package is submission-ready →

The review tells you whether your paper passes Microbiome mechanism, control, and data-readiness checks. Manusights checks do not train on your manuscript, and paid reviews include a 60-day money-back guarantee.

Microbiome requires these at first submission:

• main manuscript file in BMC Microsoft Word template format (or LaTeX equivalent; editable files required for production)
• cover letter explaining why the manuscript should be published in Microbiome, the mechanistic, functional, ecological, or clinical depth that distinguishes it from descriptive community surveys, and confirmation that all authors have approved the submission
• author byline with full names, affiliations, and ORCID iDs
• structured abstract per BMC format (Background / Methods / Results / Conclusions)
• "Availability of data and materials" section detailing data deposit accessions (NCBI SRA, ENA, DDBJ for raw reads; QIITA or MG-RAST for processed amplicon data; MetaboLights or Metabolomics Workbench for metabolomic data)
• ethics statements: IRB approval and informed consent for human-subjects sampling; IACUC approval for animal protocols; biosafety statements for regulated organisms; CITES references for any wildlife sampling
• competing-interests declaration (reviewers and editors are similarly required to declare competing interests and can be excluded from review)
• author CRediT contribution statement
• suggested reviewers with institutional email addresses (BMC enforces institutional-email verification)
• $3,890 USD APC funding declaration (institutional BMC transformative agreement, funder grant, author-paid, or LMIC waiver via Research4Life)
• declaration of generative AI use in the writing process
• for revised submissions, point-by-point reviewer response and marked-up manuscript

In our pre-submission review work for Microbiome, the most common artifact-related issue is metagenomic submissions without raw-read deposit accessions cited inline. The journal's editorial culture treats SRA/ENA/DDBJ accession-at-submission as a baseline expectation for the 22-day technical screen; submissions that promise data deposit at acceptance face routine technical-screen returns before substantive review begins.

Run a Microbiome pre-submission readiness check before clicking submit to verify the package meets the journal's mechanism-or-function-beyond-description bar.

In our pre-submission review work for Microbiome, manuscripts move through a four-stage editorial timeline shaped by the published 22-day median first-decision target and the 176-day total time to acceptance. The editorial triage pattern at BMC microbiome journals favors submissions where the cover letter names a specific failure pattern in current microbiome research (causal-vs-correlative confusion, batch-effect under-treatment, functional-vs-taxonomic-only framing) that the manuscript addresses. Editors routinely reject community-description submissions without mechanistic or functional follow-through and consistently screen for cover letters that demonstrate awareness of the journal's recent editorial culture around causal-chain rigor.

Day 0 to 3: Editorial Manager intake and BMC editorial-office technical check

The platform performs automated checks (template compliance, declarations, ethics references, ORCID linking, deposit-accession presence). BMC editorial staff verify the cover letter, data availability statement, and competing-interests declarations from suggested reviewers (in addition to authors).

Day 3 to 22: Section Editor desk-screen on causal-or-functional depth

A Section Editor (matched to gut microbiome, environmental microbiome, plant-microbiome interactions, microbiome bioinformatics and methods, or microbial ecology) reviews scope fit and whether the manuscript clears the descriptive-vs-mechanistic bar.

Week 4 to 18: External peer review (single-anonymous)

Manuscripts that pass desk-screen go to 2-3 reviewers selected for both microbiome subfield and the specific sequencing or analysis method used. Editors consult Editorial Board members where the reviewer recommendation is split.

Week 18 to 25: Decision and revision rounds

First decisions arrive at the BMC median window (176 days to acceptance overall), typically as major or minor revision. Revision cycles add 6-10 weeks each. Authors may file a formal appeal through BMC's standard appeal procedure.